drugset / Trial / NCT00433147
A Study of AT2101 (Afegostat Tartrate) in Adult Patients With Type 1 Gaucher Disease Currently Receiving Enzyme Replacement Therapy
RandomizedParallel-groupOpen-labelTreatment
Summary
This study was conducted to test the safety and tolerability of afegostat tartrate in participants with type 1 Gaucher disease already receiving enzyme replacement therapy.
Timeline
- Start
- 2007-03-23
- Primary completion
- 2008-02-19
- Completion
- 2008-02-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Afegostat | Other / unclassified | 25 mg | Oral |
| Subject | Afegostat | Other / unclassified | 150 mg | Oral |